AOD-9604 is marketed as a fat-loss fragment derived from growth hormone, positioned as lipolytic without GH side effects. What the evidence looks like: AOD-9604 has been studied in humans with a focus on safety/tolerability, including multiple randomized trials described in the literature
First of all, if you have a surgeon who offers Melanotan II injections as a service it's illegal
Better sleep patterns contribute to improved cognitive function and mood stability throughout the day
A patient with Type 2 diabetes choosing between a GLP-1 and an older oral agent is no longer making a purely glycemic decision
For both comparisons, a post hoc sensitivity analysis was performed, excluding one trial with the shortest duration and one trial with the longest duration
The GMC requires that patients are informed of alternatives, including the option of no treatment